|
The study focused on a drug known as anacetrapib, aiming for a genuinely secure control over cholesterol level. This pharmaceutical is certainly component of new medicines known as CETP inhibitors managing bad cholesterol by inducing HDLs rise (good cholesterol). In other words, the anacetrapib has the role to carry fat deposits from arteries to the liver. Afterwards, the body eliminates fat deposits.
|
